Abiopharma

Director Lockett Phyllis M 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003

Martin Samuel Bates 🟢 acquired 93.0K shares (1 derivative) of Celldex Therapeutics, Inc. (CLDX) at $34.09 ($3.2M) Transaction Date: Jun 25, 2026 | Filing ID: 000004

DUFFIELD DAVID A 🟡 adjusted position in 107.5K shares (1 derivative) of Workday, Inc. (WDAY) at $118.76 ($12.4M) Transaction Date: Jun 25, 2026 | Filing ID: 000040

Edmondson Frazor Titus III 🟡 adjusted position in 4.1K shares (1 derivative) of Zai Lab Ltd (ZLAB) at $17.46 Transaction Date: Jun 25, 2026 | Filing ID: 003123

Director Kaye Daniel G 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000005

Du Ying 🟡 adjusted position in 24.5K shares (1 derivative) of Zai Lab Ltd (ZLAB) at $17.46 Transaction Date: Jun 25, 2026 | Filing ID: 003122

Cavanaugh Sarah 🟢 acquired 95.0K shares (1 derivative) of Celldex Therapeutics, Inc. (CLDX) at $34.09 ($3.2M) Transaction Date: Jun 25, 2026 | Filing ID: 000002

(99% Neutral) LINCOLN NATIONAL CORP (LNC) Announces Business Combination

SELANDER ROBERT W 🟢 acquired 2.9K shares of HEALTHEQUITY, INC. (HQY) Transaction Date: Jun 25, 2026 | Filing ID: 000002

Chen Yajing 🟡 adjusted position in 2.3K shares (1 derivative) of Zai Lab Ltd (ZLAB) at $17.46 Transaction Date: Jun 25, 2026 | Filing ID: 003121